Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia

Oncology Reports

Volumn 36, Issue 4, 2016, Pages 1997-2008

  Chen, Min Chan ^a,b   Chen, Yi Ling ^b   Wang, Tzu Wen ^c   Hsu, Hui Ping ^c   Lai, Ming Derg ^d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Ampullary adenocarcinoma; Bile acids; CBioPortal; GPBAR1; Kaplan Meier plotter; PrognoScan; TGR5

Indexed keywords

BILE ACID; BILIRUBIN; CA 125 ANTIGEN; G PROTEIN COUPLED BILE ACID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; GPBAR1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGE; AGED; AMPULLA OF VATER; ARTICLE; BILIRUBIN BLOOD LEVEL; BIOINFORMATICS; BLOOD LEVEL; BREAST CANCER; CA 125 ANTIGEN BLOOD LEVEL; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SPECIFIC SURVIVAL; DUODENUM; FEMALE; GENE EXPRESSION; GPBAR1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REFERENCE VALUE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; WELL DIFFERENTIATED AMPULLARY ADENOCARCINOMA; WESTERN BLOTTING; ADENOCARCINOMA; BILE DUCT TUMOR; BIOSYNTHESIS; COMPLICATION; DNA MICROARRAY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; BIOMARKERS, TUMOR; BLOTTING, WESTERN; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; HYPERBILIRUBINEMIA; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84984950719     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5011     Document Type: Article

References (38)

1. Albores-Saavedra J, Schwartz AM, Batich K and Henson DE: Cancers of the ampulla of vater: Demographics, morphology, and survival based on 5, 625 cases from the SEER program. J Surg Oncol 100:598-605, 2009.
2. Tsuei J, Chau T, Mills D and Wan YJ: Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med 239:1489-1504, 2014.
3. Ye W, Chow WH, Lagergren J, Yin L and Nyrén O: Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 121:1286-1293, 2001.
4. Nishioka K, Doki Y, Miyata H, Tamura S, Yasuda T, Kimura Y, Kishi K, Yoshida K, Fujiwara Y, Yano M, et al: Bile acid promotes the proliferation of squamous cell carcinoma of the esophagus, independent of its inducing COX-2 expression. J Surg Res 132:130-135, 2006.
5. Bernstein C, Payne CM and Bernstein H: Bile acids: Promoters or carcinogens in colon cancer? J Carcinogene Mutagene 2:101e. doi:10.4172/2157-2518.1000101e, 2011.
6. Payne CM, Bernstein C, Dvorak K and Bernstein H: Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol 1:19-47, 2008.
7. Komichi D, Tazuma S, Nishioka T, Hyogo H and Chayama K: Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. Free Radic Biol Med 39:1418-1427, 2005.
8. Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH and Gores GJ: Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122:985-993, 2002.
9. Thomas C, Pellicciari R, Pruzanski M, Auwerx J and Schoonjans K: Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678-693, 2008.
10. Lax S, Schauer G, Prein K, Kapitan M, Silbert D, Berghold A, Berger A and Trauner M: Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis. Int J Cancer 130:2232-2239, 2012.
11. Van De Winkel A, Van Zoest KP, Van Dekken H, Moons LM, Kuipers EJ and Van Der Laan LJ: Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus. Histopathology 58:246-253, 2011.
12. Kim I, Morimura K, Shah Y, Yang Q, Ward JM and Gonzalez FJ: Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940-946, 2007.
13. Li T, Holmstrom SR, Kir S, Umetani M, Schmidt DR, Kliewer SA and Mangelsdorf DJ: The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol 25:1066-1071, 2011.
14. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, et al: TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10:167-177, 2009.
15. Duboc H, Taché Y and Hofmann AF: The bile acid TGR5 membrane receptor: From basic research to clinical application. Dig Liver Dis 46:302-312, 2014.
16. Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF and Resnick MB: Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol 304:G322-G327, 2013.
17. Hong J, Behar J, Wands J, Resnick M, Wang LJ, DeLellis RA, Lambeth D, Souza RF, Spechler SJ and Cao W: Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59:170-180, 2010.
18. Casaburi I, Avena P, Lanzino M, Sisci D, Giordano F, Maris P, Catalano S, Morelli C and Andò S: Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation. Cell Cycle 11:2699-2710, 2012.
19. Yang JI, Yoon JH, Myung SJ, Gwak GY, Kim W, Chung GE, Lee SH, Lee SM, Kim CY and Lee HS: Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun 361:156-161, 2007.
20. Chen WD, Yu D, Forman BM, Huang W and Wang YD: Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology 57:656-666, 2013.
21. Györffy B, Lánczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z: An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast Cancer Res Treat 123:725-731, 2010.
22. Gyorffy B, Surowiak P, Budczies J and Lanczky A: Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 8:e82241.1-e82241.8, 2013.
23. Gyorffy B, Lánczky A and Szállási Z: Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer 19:197-208, 2012.
24. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBio-Portal. Sci Signal 6: pl1, 2013.
25. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al: The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401-404, 2012.
26. Remmele W and Schicketanz KH: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 189:862-866, 1993.
27. Schiergens TS, Reu S, Neumann J, Renz BW, Niess H, Boeck S, Heinemann V, Bruns CJ, Jauch KW and Kleespies A: Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater. Surgery 158:151-161, 2015.
28. Hsu HP, Shan YS, Jin YT, Lai MD and Lin PW: Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms. J Surg Oncol 101:356-362, 2010.
29. Shan YS, Chen YL, Lai MD and Hsu HP: Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer. Oncol Rep 33:40-48, 2015.
30. Piscuoglio S, Lehmann FS, Zlobec I, Tornillo L, Dietmaier W, Hartmann A, Wünsch PH, Sessa F, Rümmele P, Baumhoer D, et al: Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. J Clin Pathol 65:140-145, 2012.
31. Rostain F, Hamza S, Drouillard A, Faivre J, Bouvier AM and Lepage C: Trends in incidence and management of cancer of the ampulla of Vater. World J Gastroenterol 20:10144-10150, 2014.
32. Hsu HP, Yang TM, Hsieh YH, Shan YS and Lin PW: Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 14:50-60, 2007.
33. Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL and Yang CS: Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18:2265-2270, 1997.
34. Pols TW, Noriega LG, Nomura M, Auwerx J and Schoonjans K: The bile acid membrane receptor TGR5: A valuable metabolic target. Dig Dis 29:37-44, 2011.
35. Stepanov V, Stankov K and Mikov M: The bile acid membrane receptor TGR5: A novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res 33:213-223, 2013.
36. Guo C, Su J, Li Z, Xiao R, Wen J, Li Y, Zhang M, Zhang X, Yu D, Huang W, et al: The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway. Oncotarget 6:34402-34413, 2015.
37. Yasuda H, Hirata S, Inoue K, Mashima H, Ohnishi H and Yoshiba M: Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun 354:154-159, 2007.
38. Jensen DD, Godfrey CB, Niklas C, Canals M, Kocan M, Poole DP, Murphy JE, Alemi F, Cottrell GS, Korbmacher C, et al: The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J Biol Chem 288:22942-22960, 2013.